Skip to content
WeighLab
Menu
Ranked #280 · Grade C

Alegro Health review

Alegro Health is a HIPAA telehealth practice based in McKinney, Texas that offers a low-cost compounded semaglutide weight-loss starter.

Visit Alegro Health Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$199/mo (starting dose, compounded)
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$2,388

The Index scorecard

Alegro Health scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month51/100
Price Transparency78/100
Nationwide Access24/100
Formulation Options53/100
Clinical Oversight74/100
Contract Flexibility61/100

Where the value is

  • Low-cost entry point: 199 dollars for a full 8-week semaglutide starter with B12
  • Direct shipping with no recurring monthly fees
  • Operates from a physical Texas medical practice with a published phone number

The tradeoffs

  • Semaglutide only; no tirzepatide offered
  • Available in select states only, which are not enumerated
  • Thin public information and compounding pharmacy not named on the site

The bottom line

Best for: Cost-first shoppers who want beginners wanting a low-cost 8-week compounded semaglutide starter with b12. Alegro Health is a HIPAA telehealth practice based in McKinney, Texas that offers a low-cost compounded semaglutide weight-loss starter.

Ranked #280 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Alegro Health.

The 18 programs nearest this one

Pricing, states and verification reflect Alegro Health's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Alegro Health's site. Not medical advice; see our disclosure.

← Back to the value leaderboard